Piper Jeffery analyst Joshua Schimmer is weighing in on the biotechnology company bluebird bio Inc (NASDAQ:BLUE) and French genome engineering company Cellectis SA (ADR) (NASDAQ:CLLS), as shares …
Piper Jaffray’s healthcare analyst Joshua Schimmer came out today with a few insights on the pharmaceutical giant Gilead Sciences, Inc. (NASDAQ:GILD) and clinical-stage biotechnology company bluebird bio …
In a research report published Thursday, Piper Jaffray analyst Joshua Schimmer reiterated a Neutral rating on shares of Repros Therapeutics Inc (NASDAQ:RPRX), while reducing …
In a research report released Thursday, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on shares of GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), with …
In a research report released today, Piper Jaffray’s healthcare analyst Joshua Schimmer reiterated an Overweight rating on shares of Insmed Incorporated (NASDAQ:INSM) with a …
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) received another set of praises from analysts at Piper Jaffray in a research report released today. The research team, …
In a research report released today, Piper Jaffray analyst Joshua Schimmer downgraded shares of MannKind Corporation (NASDAQ:MNKD) from Perform to Underperform rating, while also slashing the …
Piper Jaffray’s healthcare analyst Joshua Schimmer weighed in with his views on Amgen, Inc. (NASDAQ:AMGN), following the news that the company received FDA approval for its PCSK9 inhibitor …
In a research report released Tuesday, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on shares of Incyte Corporation (NASDAQ:INCY) with a price target of …
In a research report published Friday, Piper Jaffray analyst Joshua Schimmer reiterated an Overweight rating on shares of Avalanche Biotechnologies Inc (NASDAQ:AAVL), and reduced the …
